Print

Search Results: Prevention, Detection & Risk + Breast Cancer (7 results)

Acting on Cancer Testing Together (ACT-Together)

https://www.facingourrisk.org/research-clinical-trials/study/326/acting-on-cancer-testing-together-act-together

Prevention
This is a study for women diagnosed with BRCA 1 or BRCA2 focused on increasing education on options for reducing cancer risk associated with their diagnosis

The goal of this research study is to develop a new education program, called the ACT-Together intervention, to educate and support women who test positive for the BRCA1 or BRCA2 mutation on how they can reduce their risk of cancer in an online group setting.

Testing a Vaccine for Preventing or Treating Triple-Negative Breast Cancer

https://www.facingourrisk.org/research-clinical-trials/study/284/testing-a-vaccine-for-treating-or-preventing-triple-negative-breast-cancer

Prevention
Prevention study for people with a BRCA1, BRCA2 or PALB2 inherited mutation who are planning to undergo risk-reducing mastectomy

Researchers are studying the affects of this breast cancer vaccine on the immune system in two groups of people:

The WISDOM Study: Women Informed to Screen Depending on Measures of Risk

https://www.facingourrisk.org/research-clinical-trials/study/45/wisdom-study

Prevention
Study to determine if breast cancer screening can be made better by personalizing each woman’s mammogram schedule

The goal of the Wisdom Study is to determine if breast cancer screening can be made better by personalizing each woman’s mammogram schedule, compared to the current one-size-fits-all, annual approach. The Wisdom Study is designed to end the confusion about when to start and how often to have a mammogram. 

Restoring Sensation after DIEP Flap Reconstruction

https://www.facingourrisk.org/research-clinical-trials/study/217/restoring-sensation-after-diep-flap-reconstruction

Prevention
Study for people undergoing DIEP flap reconstruction

The goal of this study is to look at how well a nerve graft works for improving sensation to the reconstructed breast after mastectomy in people undergoing DIEP flap reconstruction (deep inferior epigastric perforator flap). 

 

Helping Latinas Understand Their Risk for Breast Cancer and Get Breast Cancer Care

https://www.facingourrisk.org/research-clinical-trials/study/250/helping-latinas-understand-their-risk-for-breast-cancer-and-get-breast-cancer-care

Prevention
Latinas with a high risk of breast cancer

This study will teach Latinas with a high risk of breast cancer about how diet, exercise, ethnicity, genetics and screening and prevention guidelines may impact their likelihood for developing breast cancer. The study will test ways of teaching participants about breast cancer and risk factors, comparing the current standard of care to new personal educational sessions. Bilingual and bicultural staff are available for the phone study to make the study open to both English and Spanish speakers.

Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA Mutations

https://www.facingourrisk.org/research-clinical-trials/study/109/blood-tests-to-measure-ovarian-reserves-in-women-with-a-brca-mutation-or-women-treated-for-early-stage-breast-cancer

Prevention
Study for premenopausal women with early-stage breast cancer and high-risk women with BRCA mutations and no evidence of breast or ovarian cancer

The purpose of this study is to see how cancer treatment affects the ovaries, such as the impact on conceiving a child or the early onset of menopause. Comparatively, the study will also look at high-risk women with BRCA1/2 mutations (and no evidence of breast or ovarian cancer).

The study will check blood levels of hormones that the ovaries produce and will use questionnaires to gather information about participant menstrual cycles, health, and pregnancies. 

Genomic Services Research Program Study for People with Unexpected Genetic Results

https://www.facingourrisk.org/research-clinical-trials/study/89/study-for-people-with-unexpected-genetic-results

Prevention
This study is recruiting people who received unexpected genetic test results about their cancer risk after having genetic testing done for some other reason

A new study is recruiting people who received unexpected genetic test results about their cancer risk after having genetic testing done for some other reason.

This is a study of people with "secondary results” from genetic testing. Secondary results are unexpected. They are not related to the reason the person had the genetic test but are shared because they may be very important to the person’s health. Most secondary results have to do with high risks for health problems that can be treated or prevented. Many of these results are related to cancer risk. If you think you have received a secondary result, you may be eligible to join this study.

Additional Results on Clinicaltrials.gov Prevention, Detection & Risk + Breast Cancer
41 results

Contrast-enhanced Spectral Mammography (CESM) Breast Cancer Screening
NCT ID: NCT04904757 (https://clinicaltrials.gov/study/NCT04904757)

Developing and Evaluating Culturally Relevant Interventions to Improve Breast Cancer Screening
NCT ID: NCT05665660 (https://clinicaltrials.gov/study/NCT05665660)

Abbreviate or FAST Breast MRI for Supplemental Breast Cancer Screening for Black Women at Average Risk and Dense Breasts
NCT ID: NCT04854304 (https://clinicaltrials.gov/study/NCT04854304)

With Love, Grandma ("Con Cariño, Abuelita") Pilot Study
NCT ID: NCT05721976 (https://clinicaltrials.gov/study/NCT05721976)

A Study to Compare the Effectiveness of Two Types of Ultrasound Technologies in Women Who Have Had Breast Cancer
NCT ID: NCT05408260 (https://clinicaltrials.gov/study/NCT05408260)

Effects of Tirzepatide on Blood, Imaging and Breast Tissue Biomarkers
NCT ID: NCT06485089 (https://clinicaltrials.gov/study/NCT06485089)

MIRAI-MRI: Comparing Screening MRI for Patients at High Risk for Breast Cancer Identified by Mirai and Tyrer-Cuzick
NCT ID: NCT05968157 (https://clinicaltrials.gov/study/NCT05968157)

FHIR-Enhanced RealRisks to Improve Accuracy of Breast Cancer Risk Assessments
NCT ID: NCT05810025 (https://clinicaltrials.gov/study/NCT05810025)

Cone Beam Breast CT for Breast Cancer Screening
NCT ID: NCT05036096 (https://clinicaltrials.gov/study/NCT05036096)

The Genomic Medicine at VA Study
NCT ID: NCT04331535 (https://clinicaltrials.gov/study/NCT04331535)

African Cancer Genome: GMD
NCT ID: NCT05754658 (https://clinicaltrials.gov/study/NCT05754658)

Testing Conversation Aid in Practice
NCT ID: NCT06011434 (https://clinicaltrials.gov/study/NCT06011434)

Delayed Sentinel Lymph Node Biopsy in Ductal Cancer in Situ
NCT ID: NCT04722692 (https://clinicaltrials.gov/study/NCT04722692)

Evaluation of the Bexa Breast Examination
NCT ID: NCT06643767 (https://clinicaltrials.gov/study/NCT06643767)

Magnetic Resonance Imaging of Breast Cancer
NCT ID: NCT01035112 (https://clinicaltrials.gov/study/NCT01035112)

Comparison of Synthetic Mammography Versus Full-Field Digital Mammography in Image Interpretation and Performance Metrics
NCT ID: NCT05056818 (https://clinicaltrials.gov/study/NCT05056818)

Promoting Informed Choice for Breast Cancer Screening: a Longitudinal Study
NCT ID: NCT05838417 (https://clinicaltrials.gov/study/NCT05838417)

Community Services Navigation to Advance Health Equity in Breast Cancer Screening
NCT ID: NCT06305312 (https://clinicaltrials.gov/study/NCT06305312)

Accurate, Rapid and Inexpensive MRI Protocol for Breast Cancer Screening
NCT ID: NCT04877912 (https://clinicaltrials.gov/study/NCT04877912)

Interventional Program Educates, Identifies + Overcomes Barriers to Complete Screening Mammography
NCT ID: NCT04348123 (https://clinicaltrials.gov/study/NCT04348123)

YES Study - Newly Diagnosed/Metastatic Intervention
NCT ID: NCT04379414 (https://clinicaltrials.gov/study/NCT04379414)

Empowering Latinas to Obtain Guideline Concordant Screenings
NCT ID: NCT05841355 (https://clinicaltrials.gov/study/NCT05841355)

Biennial CEM in Women with a Personal History of Breast Cancer
NCT ID: NCT06105749 (https://clinicaltrials.gov/study/NCT06105749)

Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies
NCT ID: NCT04152499 (https://clinicaltrials.gov/study/NCT04152499)

A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)
NCT ID: NCT04961996 (https://clinicaltrials.gov/study/NCT04961996)

Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts
NCT ID: NCT05625659 (https://clinicaltrials.gov/study/NCT05625659)

Predicting Chronic Pain Following Breast Surgery
NCT ID: NCT04967352 (https://clinicaltrials.gov/study/NCT04967352)

Connecting Black Families in Houston, Texas to Hereditary Cancer Genetic Counseling, Genetic Testing, and Cascade Testing by Using a Simple Genetic Risk Screening Tool and Telegenetics
NCT ID: NCT05694559 (https://clinicaltrials.gov/study/NCT05694559)

A Multi-Modality Surveillance Program for Women at High Risk for Breast Cancer
NCT ID: NCT03729115 (https://clinicaltrials.gov/study/NCT03729115)

Long-term Safety of Nipple Sparing Mastectomy in Women With GPV in Breast Cancer
NCT ID: NCT06888388 (https://clinicaltrials.gov/study/NCT06888388)

Evaluating an Evidence-Based Family History Screening Program Adapted to Increase Reach and Uptake of Screening for BRCA-Associated Cancers in Rural Public Health Clinics
NCT ID: NCT06760507 (https://clinicaltrials.gov/study/NCT06760507)

Project 1: Self-Triage by 2D Full-field Digital Mammography or Synthetic Images
NCT ID: NCT05960188 (https://clinicaltrials.gov/study/NCT05960188)

Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer
NCT ID: NCT04030507 (https://clinicaltrials.gov/study/NCT04030507)

Breast Cancer AI Imaging Study
NCT ID: NCT06604078 (https://clinicaltrials.gov/study/NCT06604078)

Rutgers University Study of the Genetics of Breast Cancer.
NCT ID: NCT06773897 (https://clinicaltrials.gov/study/NCT06773897)

The C-MERIT Screening Cohort: Contrast-enhanced Mammography for Breast Cancer Screening and Risk Assessment in Women With Dense Breasts
NCT ID: NCT05667532 (https://clinicaltrials.gov/study/NCT05667532)

Empowering Vulnerable and Resilient Latinas to Obtain Breast Cancer Care
NCT ID: NCT05483283 (https://clinicaltrials.gov/study/NCT05483283)

Early Detection of Breast Cancer
NCT ID: NCT06043661 (https://clinicaltrials.gov/study/NCT06043661)

A Validation Study to Determine Concordance of Liquid Biopsy and Breast Cancer Diagnosis
NCT ID: NCT06336928 (https://clinicaltrials.gov/study/NCT06336928)

Impact of Dietary Inflammatory Potential on Breast Cancer Risk
NCT ID: NCT05178498 (https://clinicaltrials.gov/study/NCT05178498)

Faith in Action! A Church-Based Navigation Model to Increase Breast Cancer Screening in Korean Women
NCT ID: NCT05298605 (https://clinicaltrials.gov/study/NCT05298605)

About FORCE

FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.